...
首页> 外文期刊>Antioxidants and redox signalling >Redox regulation of the influenza hemagglutinin maturation process: a new cell-mediated strategy for anti-influenza therapy.
【24h】

Redox regulation of the influenza hemagglutinin maturation process: a new cell-mediated strategy for anti-influenza therapy.

机译:流感血凝素成熟过程的氧化还原调节:抗流感治疗的新的细胞介导策略。

获取原文
获取原文并翻译 | 示例

摘要

AIM: The aim of this study was to determine whether GSH-C4, a hydrophobic glutathione derivative, affects in vitro and in vivo influenza virus infection by interfering with redox-sensitive intracellular pathways involved in the maturation of viral hemagglutinin (HA). RESULTS: GSH-C4 strongly inhibited influenza A virus replication in cultured cells and in lethally infected mice, where it also reduced lung damage and mortality. In cell-culture studies, GSH-C4 arrested viral HA folding; the disulfide-rich glycoprotein remained in the endoplasmic reticulum as a reduced monomer instead of undergoing oligomerization and cell plasma-membrane insertion. HA maturation depends on the host-cell oxidoreductase, protein disulfide isomerase (PDI), whose activity in infected cells is probably facilitated by virus-induced glutathione depletion. By correcting this deficit, GSH-C4 increased levels of reduced PDI and inhibited essential disulfide bond formation in HA. Host-cell glycoprotein expression in uninfected cells was unaffected by glutathione, which thus appears to act exclusively on glutathione-depleted cells. INNOVATION: All currently approved anti-influenza drugs target essential viral structures, and their efficacy is limited by toxicity and by the almost inevitable selection of drug-resistant viral mutants. GSH-C4 inhibits influenza virus replication by modulating redox-sensitive pathways in infected cells, without producing toxicity in uninfected cells or animals. Novel anti-influenza drugs that target intracellular pathways essential for viral replication ("cell-based approach") offer two important potential advantages: they are more difficult for the virus to adapt to and their efficacy should not be dependent on virus type, strain, or antigenic properties. CONCLUSION: Redox-sensitive host-cell pathways exploited for viral replication are promising targets for effective anti-influenza strategies.
机译:目的:本研究的目的是确定疏水性谷胱甘肽衍生物GSH-C4是否通过干扰参与病毒血凝素(HA)成熟的氧化还原敏感的细胞内途径来影响体外和体内流感病毒感染。结果:GSH-C4强烈抑制了培养细胞和致死感染小鼠中的甲型流感病毒复制,还降低了肺损伤和死亡率。在细胞培养研究中,GSH-C4阻止了病毒HA折叠。富含二硫键的糖蛋白以还原单体的形式保留在内质网中,而不进行寡聚化和细胞质膜插入。 HA的成熟取决于宿主细胞的氧化还原酶,蛋白质二硫键异构酶(PDI),其在感染细胞中的活性可能是由病毒引起的谷胱甘肽耗竭而促进的。通过纠正这一缺陷,GSH-C4增加了降低的PDI水平,并抑制了HA中必需的二硫键形成。未被感染的细胞中的宿主细胞糖蛋白表达不受谷胱甘肽的影响,因此似乎仅对耗尽谷胱甘肽的细胞起作用。创新:目前所有已批准的抗流感药物均以必需的病毒结构为靶标,其功效受到毒性和几乎不可避免的耐药性病毒突变体选择的限制。 GSH-C4通过调节感染细胞中的氧化还原敏感途径来抑制流感病毒复制,而不会在未感染细胞或动物中产生毒性。靶向病毒复制必不可少的细胞内途径的新型抗流感药物(“基于细胞的方法”)具有两个重要的潜在优势:它们对病毒的适应更加困难,其功效不应取决于病毒类型,株系,或抗原性。结论:用于病毒复制的氧化还原敏感的宿主细胞途径是有效的抗流感策略的有希望的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号